In January, the firm announced it entered into a nonbinding letter of intent to purchase 3% of the California-based cannabis management and investment firm MedMen Enterprises for $30 million. The numbers indicate a valuation of roughly $1 billion, which some observers in the industry have scoffed at.
read more here
Delivered by @can_nab_is
No comments:
Post a Comment